Invesco S&P SmallCap Health Care ETF(PSCH · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$47.78
- 52-Week Range
- $37.45 – $48.23
- YTD
- +8.95%
- IV Rank (30D)
- 25.68
- Straddle Price
- $3.45
Info
Invesco S&P SmallCap Health Care ETF (PSCH) ETF
- Exchange
- XNAS
- Inception
- 2010-04-07
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-11
Holdings
81
AUM
$139.5M
Provider
Invesco
Inception
2010-04-07
Exchange
XNAS
Data As Of
2026-06-11
Expense Ratio
—
Dividend Yield
0.01%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-03-23 | 2026-03-27 | $0.0003 | CD |
| 2025-09-22 | 2025-09-26 | $0.0026 | CD |
| 2025-06-23 | 2025-06-27 | $0.0020 | CD |
| 2025-03-24 | 2025-03-28 | $0.0142 | CD |
| 2024-12-23 | 2024-12-27 | $0.0180 | CD |
| 2024-06-24 | 2024-06-28 | $0.0659 | CD |
Asset Allocation
Top Holdings
top 50 of 81 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| MOH | Molina Healthcare Inc | 4.99% | Equity (US) | — |
| BTSG | BrightSpring Health Services Inc | 4.62% | Equity (US) | — |
| KRYS | Krystal Biotech Inc | 4.16% | Equity (US) | — |
| CORT | Corcept Therapeutics Inc | 3.91% | Equity (US) | — |
| ALKS | Alkermes PLC | 3.72% | Equity (US) | — |
| GKOS | Glaukos Corp | 3.58% | Equity (US) | — |
| TGTX | TG Therapeutics Inc | 3.28% | Equity (US) | — |
| PTGX | Protagonist Therapeutics Inc | 3.24% | Equity (US) | — |
| PTCT | PTC Therapeutics Inc | 3.01% | Equity (US) | — |
| TFX | Teleflex Inc | 2.88% | Equity (US) | — |
| LGND | Ligand Pharmaceuticals Inc | 2.51% | Equity (US) | — |
| INDV | Indivior Pharmaceuticals Inc | 2.39% | Equity (US) | — |
| RDNT | RadNet Inc | 2.03% | Equity (US) | — |
| MMSI | Merit Medical Systems Inc | 1.99% | Equity (US) | — |
| VCYT | Veracyte Inc | 1.88% | Equity (US) | — |
| CPRX | Catalyst Pharmaceuticals Inc | 1.82% | Equity (US) | — |
| ICUI | ICU Medical Inc | 1.77% | Equity (US) | — |
| OGN | Organon & Co | 1.75% | Equity (US) | — |
| CON | Concentra Group Holdings Parent Inc | 1.63% | Equity (US) | — |
| ALHC | Alignment Healthcare Inc | 1.63% | Equity (US) | — |
| ITGR | Integer Holdings Corp | 1.62% | Equity (US) | — |
| AMRX | Amneal Pharmaceuticals Inc | 1.39% | Equity (US) | — |
| PRVA | Privia Health Group Inc | 1.36% | Equity (US) | — |
| ACAD | ACADIA Pharmaceuticals Inc | 1.34% | Equity (US) | — |
| SUPN | Supernus Pharmaceuticals Inc | 1.31% | Equity (US) | — |
| TMDX | TransMedics Group Inc | 1.26% | Equity (US) | — |
| NHC | National HealthCare Corp | 1.22% | Equity (US) | — |
| ACHC | Acadia Healthcare Co Inc | 1.15% | Equity (US) | — |
| PBH | Prestige Consumer Healthcare Inc | 1.13% | Equity (US) | — |
| WAY | Waystar Holding Corp | 1.06% | Equity (US) | — |
| PGNY | Progyny Inc | 1.03% | Equity (US) | — |
| MD | Pediatrix Medical Group Inc | 1.02% | Equity (US) | — |
| NEOG | Neogen Corp | 1.01% | Equity (US) | — |
| ADMA | ADMA Biologics Inc | 0.99% | Equity (US) | — |
| RCUS | Arcus Biosciences Inc | 0.99% | Equity (US) | — |
| VCEL | Vericel Corp | 0.98% | Equity (US) | — |
| LFST | LifeStance Health Group Inc | 0.97% | Equity (US) | — |
| LMAT | LeMaitre Vascular Inc | 0.97% | Equity (US) | — |
| CRVL | CorVel Corp | 0.95% | Equity (US) | — |
| UFPT | UFP Technologies Inc | 0.92% | Equity (US) | — |
| SEM | Select Medical Holdings Corp | 0.92% | Equity (US) | — |
| ASTH | Astrana Health Inc | 0.86% | Equity (US) | — |
| OMCL | Omnicell Inc | 0.85% | Equity (US) | — |
| ADUS | Addus HomeCare Corp | 0.85% | Equity (US) | — |
| INVA | Innoviva Inc | 0.80% | Equity (US) | — |
| SRPT | Sarepta Therapeutics Inc | 0.79% | Equity (US) | — |
| FTRE | Fortrea Holdings Inc | 0.78% | Equity (US) | — |
| PRGO | Perrigo Co PLC | 0.77% | Equity (US) | — |
| NEO | NeoGenomics Inc | 0.74% | Equity (US) | — |
| ANIP | ANI Pharmaceuticals Inc | 0.74% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
Invesco S&P SmallCap Health Care ETF ·
NPORT-P period 2026-08-31
(filed 2026-04-28)
Net assets:
$140M
· 80 total positions
· equity 102.18%
· non-equity 29.32%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Krystal Biotech, Inc. | Krystal Biotech, Inc. | 4.24% | $5.9M |
| 2 | Glaukos Corp. | Glaukos Corp. | 4.12% | $5.8M |
| 3 | PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | 3.26% | $4.6M |
| 4 | Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | 3.22% | $4.5M |
| 5 | Teleflex Inc. | Teleflex Inc. | 3.21% | $4.5M |
| 6 | Alkermes PLC | Alkermes PLC | 2.96% | $4.1M |
| 7 | TransMedics Group, Inc. | TransMedics Group, Inc. | 2.96% | $4.1M |
| 8 | RadNet, Inc. | RadNet, Inc. | 2.89% | $4.0M |
| 9 | BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | 2.80% | $3.9M |
| 10 | Merit Medical Systems, Inc. | Merit Medical Systems, Inc. | 2.73% | $3.8M |
| 11 | TG Therapeutics, Inc. | TG Therapeutics, Inc. | 2.44% | $3.4M |
| 12 | Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | 2.43% | $3.4M |
| 13 | Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | 2.32% | $3.2M |
| 14 | ICU Medical, Inc. | ICU Medical, Inc. | 2.21% | $3.1M |
| 15 | ADMA Biologics, Inc. | ADMA Biologics, Inc. | 2.21% | $3.1M |
| 16 | Corcept Therapeutics Inc. | Corcept Therapeutics Inc. | 1.99% | $2.8M |
| 17 | Prestige Consumer Healthcare Inc. | Prestige Consumer Healthcare Inc. | 1.98% | $2.8M |
| 18 | Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | 1.87% | $2.6M |
| 19 | Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | 1.83% | $2.6M |
| 20 | Integer Holdings Corp. | Integer Holdings Corp. | 1.81% | $2.5M |
| 21 | Waystar Holding Corp. | Waystar Holding Corp. | 1.75% | $2.5M |
| 22 | Veracyte, Inc. | Veracyte, Inc. | 1.72% | $2.4M |
| 23 | Concentra Group Holdings Parent, Inc. | Concentra Group Holdings Parent, Inc. | 1.70% | $2.4M |
| 24 | Privia Health Group, Inc. | Privia Health Group, Inc. | 1.64% | $2.3M |
| 25 | Catalyst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. | 1.59% | $2.2M |
Showing top 25 of 77 equity holdings.
Non-equity holdings
— 3 positions,
29.32% of NAV
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 29.32% | $41.0M | 3 |
Daily issuer data also available
(2026-06-13)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +1.44% | 15 |
| Feb | +0.63% | 15 |
| Mar | +0.08% | 16 |
| Apr | +0.59% | 16 |
| May | +1.09% | 16 |
| Jun | +2.79% | 16 |
| Jul | +1.54% | 15 |
| Aug | +0.21% | 15 |
| Sep | -1.94% | 15 |
| Oct | -0.33% | 15 |
| Nov | +5.66% | 15 |
| Dec | -0.42% | 15 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $45.51
SMA 50: $44.63
SMA 200: $43.37
Current: $47.79
EMA 12: $46.38
EMA 26: $45.60
MACD: 0.7821 | Signal: 0.2515
BULLISH
ADX (14): 24.47
WEAK TREND
+DI: 36.19
−DI: 12.44
Momentum Oscillators
RSI (14): 70.30
OVERBOUGHT
Stoch %K: 87.52
Stoch %D: 87.83
Williams %R: -10.76
Volume & Volatility
BB Upper: $47.74
BB Lower: $43.28
OVERBOUGHT
OBV: 678,845
Vol SMA 20: 10,407
Vol ROC: -33.72%
ATR: $0.72
True Range: $0.60
HV 20: 19.8%
HV 30: 17.2%
HV 60: 21.2%
Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:22.966000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 25.68
- IV Rank (7D)
- 69.95
- Avg IV
- 28.4%
- Straddle (30D)
- $3.45
- Straddle (7D)
- $2.35
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 1.05
- Correlation (SPY)
- 63.3%
- R²
- 0.40
- Ann. Volatility
- 20.6%
- SPY Volatility
- 12.3%
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|